Second-line medications for women aged 10 to 50 years with idiopathic generalized epilepsy
Second-line medications for women aged 10 to 50 years with idiopathic generalized epilepsy
Cox proportional hazards regression, antiseizure medications (ASMs), idiopathic generalized epilepsy (IGE), Neurology and neuromuscular diseases, Adolescent health, Paediatrics, add-on therapy, limited options, valproic acid, Central nervous system, Infant and child health, Reproductive medicine, Treatment failure (TF), women, inverse probability of treatment weighting (IPTW), substitution monotherapy, Clinical pharmacology and therapeutics
Cox proportional hazards regression, antiseizure medications (ASMs), idiopathic generalized epilepsy (IGE), Neurology and neuromuscular diseases, Adolescent health, Paediatrics, add-on therapy, limited options, valproic acid, Central nervous system, Infant and child health, Reproductive medicine, Treatment failure (TF), women, inverse probability of treatment weighting (IPTW), substitution monotherapy, Clinical pharmacology and therapeutics
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).0 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!